Location: Home
  • search
  • go
  • Relate News
  • 11/22/2013NHFPC Highlights Ten Areas of Future Healthcare Reform
  • 11/22/2013CFDA Drafts New Notice to Strengthen Regulation of TCM Extracts
  • 11/22/2013CFDA Orders Disclosure of Toxic Ingredients in TCMs
  • 11/21/2013IMS Health: China Pharmaceutical Market Snapshot in Q2/2013
  • 11/21/2013Aetna Appoints Former Merck Executive to GM Greater China
  • 11/21/2013Adimmune Approved to Conduct Phase III Trials of Its Flu Vaccine in Ch...
  • 11/21/2013CFDA Issues Warning on ADRs of Fluoroquinolones
  • 11/20/2013Diabetes Prevalence Rises Faster in Rural Areas
  • 11/20/2013India to Launch New Measure to Restrict Foreign Investment in Pharma I...
  • 11/20/2013NDRC to Hold Forum on Drug Pricing This Week
  • 11/20/2013China to Introduce 15 More Healthcare Reform Implementation Regulation...
  • 11/20/2013Hengrui Makes Progress with Registration of Two Major New Products
  • 11/20/2013Catalent Pharma Opens Its First Clinical Supply Facility in China
  • 11/19/2013Review of Hospital Drug Consumption in Six Cities of Yangtze River Vic...
  • 11/19/2013Patheon, DSM to Merge Pharmaceutical Business
  • 11/19/2013WuXi PharmaTech Subsidiary Enters Supply Arrangement with Pharmacyclic...
  • 11/19/2013Nicholas Hall Reports Fresh Data on the Chinese OTC Analgesics Market
  • 11/19/2013Nicholas Hall Reports New Data on the Chinese OTC Oral Care Market
  • 11/19/2013Executive Moves
  • 11/19/2013Beijing Makes Progress with Experiment of Separating Medical Services ...
  • 11/19/2013Shanghai to Kick Off Centralized Tender Purchase of Non-essential Drug...
  • 11/19/2013Mallinckrodt, China Resources Pharma Enter Partnership to Market Optir...
  • 11/18/2013New Report: Chinese Vaccine Market Expanding
  • 11/18/2013Eli Lilly Invests US$350M to Expand Its Insulin Cartridge Production C...
  • 11/18/2013Review of Chinese Pharmaceutical Industry Performance in the 1H/2013
  • 11/18/2013Chengdu Adopts "Secondary Negotiation" for Drug Purchases by...
  • 11/18/2013Lung Cancer Patients to Reach 1M in China by 2025
  • 11/15/2013China's Generic Drug Bioequivalence Study Plan in Technical Disarray
  • 11/15/2013J&J to Invest US$300M for Largest Manufacturing Facility Globally ...
  • 11/15/2013China's Pharma Potential Diminished (External)
  • Page:488/773 Total number of articles:23188: [First][<<] [486] [487] [488] [489] [490] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group